IRIS Accounts Production v25.4.0.155 08001193 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080011932024-03-31080011932025-03-31080011932024-04-012025-03-31080011932023-03-31080011932023-04-012024-03-31080011932024-03-3108001193ns15:EnglandWales2024-04-012025-03-3108001193ns14:PoundSterling2024-04-012025-03-3108001193ns10:Director12024-04-012025-03-3108001193ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108001193ns10:SmallEntities2024-04-012025-03-3108001193ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3108001193ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3108001193ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108001193ns10:FullAccounts2024-04-012025-03-3108001193ns10:OrdinaryShareClass22024-04-012025-03-3108001193ns10:OrdinaryShareClass32024-04-012025-03-3108001193ns10:OrdinaryShareClass42024-04-012025-03-3108001193ns10:OrdinaryShareClass52024-04-012025-03-3108001193ns10:Director22024-04-012025-03-3108001193ns10:RegisteredOffice2024-04-012025-03-3108001193ns5:CurrentFinancialInstruments2025-03-3108001193ns5:CurrentFinancialInstruments2024-03-3108001193ns5:Non-currentFinancialInstruments2025-03-3108001193ns5:Non-currentFinancialInstruments2024-03-3108001193ns5:ShareCapital2025-03-3108001193ns5:ShareCapital2024-03-3108001193ns5:RetainedEarningsAccumulatedLosses2025-03-3108001193ns5:RetainedEarningsAccumulatedLosses2024-03-3108001193ns5:MotorVehicles2024-04-012025-03-3108001193ns5:ComputerEquipment2024-04-012025-03-3108001193ns5:MotorVehicles2024-03-3108001193ns5:ComputerEquipment2024-03-3108001193ns5:MotorVehicles2025-03-3108001193ns5:ComputerEquipment2025-03-3108001193ns5:MotorVehicles2024-03-3108001193ns5:ComputerEquipment2024-03-3108001193ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108001193ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108001193ns5:CurrentFinancialInstruments2024-04-012025-03-3108001193ns5:DeferredTaxation2024-03-3108001193ns5:DeferredTaxation2025-03-3108001193ns10:OrdinaryShareClass22025-03-3108001193ns10:OrdinaryShareClass32025-03-3108001193ns10:OrdinaryShareClass42025-03-3108001193ns10:OrdinaryShareClass52025-03-3108001193ns10:Director112024-03-3108001193ns10:Director112023-03-3108001193ns10:Director112024-04-012025-03-3108001193ns10:Director112023-04-012024-03-3108001193ns10:Director112025-03-3108001193ns10:Director112024-03-31
REGISTERED NUMBER: 08001193 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

WHEELER SCIENCE MEDICINE & EDUCATION LTD

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WHEELER SCIENCE MEDICINE & EDUCATION LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: D W Wheeler
S J Wheeler





REGISTERED OFFICE: c/o Thompson Taraz Rand
Suite 20, New Cambridge House
Bassingbourn Road
Litlington
Cambridgeshire
SG8 0SS





BUSINESS ADDRESS: Heatherlea
Carnoch
Glencoe
Bellachulish
Argyll
PH49 4HQ





REGISTERED NUMBER: 08001193 (England and Wales)





ACCOUNTANTS: Thompson Taraz Rand Ltd
Chartered Accountants
10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 5 86,901 36,297

CURRENT ASSETS
Debtors 6 109,578 80,396
Cash and cash equivalents 35,609 39,286
145,187 119,682
CREDITORS
Amounts falling due within one year 7 (32,456 ) (29,672 )
NET CURRENT ASSETS 112,731 90,010
TOTAL ASSETS LESS CURRENT LIABILITIES 199,632 126,307

CREDITORS
Amounts falling due after more than one
year

8

(44,620

)

-

PROVISIONS FOR LIABILITIES 11 (21,725 ) (9,074 )
NET ASSETS 133,287 117,233

CAPITAL AND RESERVES
Called up share capital 12 100 100
Retained earnings 133,187 117,133
SHAREHOLDERS' FUNDS 133,287 117,233

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 November 2025 and were signed on its behalf by:





D W Wheeler - Director


WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Wheeler Science Medicine & Education Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Revenue recognition
Turnover shown in the profit and loss account represents the invoiced sales in relation to the provision of medical consultancy services.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Motor vehicles - 25% on reducing balance
Equipment - 33.33% on cost

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any.

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 5 ) .

5. TANGIBLE FIXED ASSETS
Motor
vehicles Equipment Totals
£    £    £   
COST
At 1 April 2024 74,318 16,640 90,958
Additions 90,990 1,082 92,072
Disposals (41,129 ) (767 ) (41,896 )
At 31 March 2025 124,179 16,955 141,134
DEPRECIATION
At 1 April 2024 44,529 10,132 54,661
Charge for year 27,415 2,607 30,022
Eliminated on disposal (30,009 ) (441 ) (30,450 )
At 31 March 2025 41,935 12,298 54,233
NET BOOK VALUE
At 31 March 2025 82,244 4,657 86,901
At 31 March 2024 29,789 6,508 36,297


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 50,892 71,089
Amounts owed by associates 14,942 -
Other debtors 42,851 5,921
Directors' current accounts 893 3,386
109,578 80,396

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Hire purchase contracts (see note 9) 14,870 -
Trade creditors 55 -
Corporation tax - 10,418
Social security and other taxes 84 155
VAT 15,877 17,602
Accrued expenses 1,570 1,497
32,456 29,672

The directors' current accounts are repayable on demand and interest free.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Hire purchase contracts (see note 9) 44,620 -

9. LEASING AGREEMENTS

Assets held under finance leases, which are leases where substantially all the risks and rewards of ownership have passed to the company, are capitalised in the balance sheet as a tangible fixed asset and are depreciated over the shorter of the lease term and their useful lives. The capital elements of future obligations under the leases are included as liabilities in the balance sheet. The interest element of the rental obligation is charged to the profit and loss account.

10. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Hire purchase contracts 59,490 -

Liabilities held under hire purchase agreements are secured against the asset to which they relate.

11. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 21,725 9,074

Deferred
tax
£   
Balance at 1 April 2024 9,074
Charge for the year 12,651
Balance at 31 March 2025 21,725

The provision for deferred taxation is made up of accelerated capital allowances.

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
55 Ordinary A £1 55 55
30 Ordinary B £1 30 30
5 Ordinary C £1 5 5
5 Ordinary D £1 5 5
5 Ordinary E £1 5 5
100 100

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

13. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
D W Wheeler
Balance outstanding at start of year 3,386 -
Amounts advanced 893 3,386
Amounts repaid (3,386 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 893 3,386

14. RELATED PARTY DISCLOSURES

At the balance sheet date, the director had an outstanding director's loan account balance of £893 (2024: £3,386) which is disclosed in other debtors. This amount bears no interest and there is no agreed repayable date.


At the balance sheet date, the company was owed £14,942 from Brooks and Wren Properties Ltd, which is also under control of the director. This amount bears no interest and there is no agreed repayable date.